title: MR cholangiopancreatography: improved ductal distention with intravenous morphine administration.
abstract: Magnetic resonance (MR) cholangiopancreatography has proved a robust and noninvasive imaging modality for evaluating the biliary and pancreatic ducts without the use of ionizing radiation. Although MR cholangiopancreatography reliably depicts the main extrahepatic and intrahepatic bile ducts, it does not depict the segmental intrahepatic ducts unless they are dilated. The segmental ducts are difficult to visualize with MR cholangiopancreatography because of their small caliber and the limited spatial resolution and signal-to-noise ratio achievable with standard MR pulse sequences. However, visualization of the normal (ie, nondistended) biliary system is necessary for the evaluation of donor candidates for living related liver transplantation. Because of the prevalence of variant biliary anatomy, MR cholangiopancreatography is often used for preoperative evaluation of prospective liver donors. Intravenous morphine administered prior to MR cholangiopancreatography can improve image quality by causing the sphincter of Oddi to contract, which increases pressure in and distention of the biliary and pancreatic ducts. Morphine administration may also be particularly helpful for the evaluation of patients with primary sclerosing cholangitis, malignant neoplasms such as cholangiocarcinoma, or cystic and non-organ-deforming benign pancreatic neoplasms.
authors.affiliation: Department of Diagnostic Radiology, Mayo Clinic Scottsdale, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA. silva.alvin@mayo.edu
authors.forename: Alvin C
authors.initials: AC
authors.lastname: Silva
authors.forename: Jeremy L
authors.initials: JL
authors.lastname: Friese
authors.forename: Amy K
authors.initials: AK
authors.lastname: Hara
authors.forename: Patrick T
authors.initials: PT
authors.lastname: Liu
mesh_terms: D001649:Bile Duct Diseases / Q000175:diagnosis / Q000473:pathology; D001652:Bile Ducts / Q000033:anatomy & histology / Q000473:pathology*; D002277:Carcinoma / Q000175:diagnosis / Q000473:pathology; D018281:Cholangiocarcinoma / Q000473:pathology; D003937:Diagnosis, Differential; D005706:Gallbladder Neoplasms / Q000473:pathology; D014644:Genetic Variation; D006500:Hepatic Duct, Common / Q000033:anatomy & histology / Q000473:pathology; D006801:Humans; D016031:Liver Transplantation; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009020:Morphine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D010182:Pancreatic Diseases / Q000175:diagnosis / Q000473:pathology; D010183:Pancreatic Ducts / Q000033:anatomy & histology / Q000473:pathology*; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000473:pathology; D010195:Pancreatitis / Q000175:diagnosis / Q000473:pathology; D009803:Sphincter of Oddi / Q000187:drug effects; D014019:Tissue Donors
chemical_list: D009020:Morphine